Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CareDx
AddedFeb 19, 2024
UpdatedJun 18, 2026
CareDx

CareDx

Public

CareDx, Inc., a California-based medical firm, specializes in molecular diagnostics for transplant medicine and autoimmunity.

HQ
Brisbane, CA, US
Founded
1999
Overview
Compare
Fundraising
Employees
News
Website

CareDx is a molecular diagnostics company focused on transplant medicine and autoimmunity. Based in California, the firm offers a range of services and products tailored to the transplant journey, including transplant services, lab products, and digital solutions. CareDx's mission centers on providing personalized care for transplant patients, emphasizing innovation and a 100% focus on transplantation.

The company has made significant strides in the field, with landmark studies published in heart and kidney transplantation. CareDx's comprehensive approach encompasses various aspects of transplant care, from diagnostic services to digital health solutions. They also offer pharma services, demonstrating a broad impact on the transplant medicine landscape.

CareDx - Similar Companies

IncellDx logo

IncellDx

healthbioai.com

TAI Diagnostics logo

TAI Diagnostics

SynapDx logo

SynapDx

DxNA logo

DxNA

DxTerity Diagnostics logo

DxTerity Diagnostics

dxterity.com

Quest Diagnostics logo

Quest Diagnostics

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Molecular Stethoscope logo

Molecular Stethoscope

Test Diagnostics logo

Test Diagnostics

Ischemia Care logo

Ischemia Care

ischemiacare.com

NAT Diagnostics logo

NAT Diagnostics

DxDiscovery logo

DxDiscovery

dxdiscovery.com

Molecular Detection logo

Molecular Detection

Biodesix logo

Biodesix

biodesix.com

Neodiagnostix logo

Neodiagnostix

neodiagnostix.com

CareDx - Quick Facts

Who are CareDx's competitors?

Companies similar to CareDx include IncellDx, TAI Diagnostics, SynapDx and DxNA.

When was CareDx founded?

CareDx was founded in 1999.

Where is CareDx's headquarters located?

CareDx's headquarters is located in Brisbane, CA, US.

When was CareDx's last funding round?

CareDx's most recent funding round was for $164M (USD) in January 2021.

How much has CareDx raised to-date?

As of Jan 21, 2021, CareDx has raised a total of $574.9M (USD).

How many employees does CareDx have?

CareDx has 770 employees as of Feb 6, 2024.

CareDx - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Testing
Tags
  • Data
  • Healthtech
Unique IDs
  • ein: 943316839
  • secCik: 0001217234
  • ticker: CDNA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified